Publications by authors named "Tamara Codilupi"

Claim this Profile
J
Jak2V617F Reversible Activation Shows Its Essential Requirement in Myeloproliferative Neoplasms.
Andrew J Dunbar, Robert L Bowman, Young C Park, Kavi O'Connor, Franco Izzo, Tamara Codilupi

Cancer Discov· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of Resistance to Type II JAK2 Inhibitors in MPN Depends on AXL Kinase and Is Targetable.
Tamara Codilupi, Jakub Szybinski, Stefanie Arunasalam, Sarah Jungius, Andrew C Dunbar

Clin Cancer Res· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CRL4 ubiquitin ligase stimulates Fanconi anemia pathway-induced single-stranded DNA-RPA signaling.
Tamara Codilupi, Doreen Taube, Hanspeter Naegeli

BMC Cancer· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting compensatory MEK/ERK activation increases JAK inhibitor efficacy in myeloproliferative neoplasms.
Simona Stivala, Tamara Codilupi, Sime Brkic, Anne Baerenwaldt, Nilabh Ghosh

J Clin Invest· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chromatin remodeler CHD1 promotes XPC-to-TFIIH handover of nucleosomal UV lesions in nucleotide excision repair.
Peter Rüthemann, Chiara Balbo Pogliano, Tamara Codilupi, Zuzana Garajovà, Hanspeter Naegeli

EMBO J· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis